Biomarkers

Datasheets

Datasheets

COVID-19 Serology Testing

Synexa’s validated assay detects IgG, IgM, IgA and SARS-CoV-2 nAbs.

October 21, 2020

COVID-19: Biomarker Analysis

Synexa provides a large portfolio of biomarkers for COVID-19 therapeutic and vaccine development.

October 21, 2020

Biosimilar Research and Development Expertise

Synexa provides PK and ADA solutions for biosimilars according to a sponsor’s priorities and requirements.

October 21, 2020

Measurement of phosphorylated SMAD-2/3

In fibrotic disease, deposition of extracellular matrix (ECM) proteins is increased. This compromises tissue architecture and interferes with normal organ function.

October 1, 2020